Merck & Co., Inc. (0QAH)
LSE
Closed
Oct 6, 2026
Day's Range
139.3052 wk Range
81.90Profile - 0QAH - Merck & Co., Inc.
Profile
Mic Code
XLON
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
73K
Merck & Co., Inc. operates as a leading healthcare company worldwide, specializing in the research, development, and commercialization of innovative pharmaceutical products and vaccines. Its portfolio features prominent human health pharmaceuticals such as Keytruda for oncology treatments, Welireg for specific cancer therapies, and Gardasil for HPV prevention. The company also provides a robust lineup of vaccines including ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, and Pneumovax 23, addressing infectious diseases across age groups. Additional offerings include Bridion for surgical care. Merck & Co., Inc. focuses on key therapeutic areas like oncology, vaccines, hospital acute care, and immunology, serving patients, healthcare providers, and global health systems. Through its operations, the company plays a vital role in advancing treatments for serious diseases and preventive health measures. Founded in 1891 and headquartered in Rahway, New Jersey, Merck & Co., Inc. maintains a strong presence in the biopharmaceutical sector, contributing to global health solutions.
Profile Details
Type
Common Stock
Address
126 East Lincoln Avenue
City
Rahway
State
NJ
Zip
07065
Country
United States
Phone
908 740 4000
Key Executives - 0QAH - Merck & Co., Inc.
Key executives
Cross Listings - 0QAH - Merck & Co., Inc.
Also listed on
The same company trading on other exchanges.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
